Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
1. Registration Statement (Form S-8, No. 333-257920) pertaining to the 2021 Equity Incentive Plan and the 2021 Employee Stock Purchase Plan of Cyteir Therapeutics, Inc.,
2. Registration Statement (Form S-8, No. 333-263607) pertaining to the 2021 Equity Incentive Plan of Cyteir Therapeutics, Inc., and
3. Registration Statement (Form S-3, No. 333-266676) and related Prospectus of Cyteir Therapeutics, Inc. for the registration of common stock, preferred stock, debt securities, warrants and units;
of our report dated March 23, 2023, with respect to the consolidated financial statements of Cyteir Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2022.
/s/ Ernst & Young LLP
|
Boston, Massachusetts |
March 23, 2023 |